Balance Sheet
Accounts PayablesAssetsCommon EquityLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exousia Bio (LMMY) Accumulated Expenses (2023 - 2024)

Lamy (LMMY) has disclosed Accumulated Expenses for 2 consecutive years, with $1211.0 as the latest value for Q3 2024.

  • Quarterly Accumulated Expenses fell 72.16% to $1211.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $1211.0 through Aug 2024, down 72.16% year-over-year, with the annual reading at $11079.0 for FY2024, 1716.23% up from the prior year.
  • Accumulated Expenses hit $1211.0 in Q3 2024 for Lamy, down from $11079.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $11079.0 in Q2 2024 to a low of $610.0 in Q2 2023.